Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Irinotecan manufacturers

6 products found

Filters

Filters

Filters , active

Country of origin : China

Clear all

6 products found

irinotecan

Solution for infusion 40mg/2ml 100mg/5ml 300mg/15ml 500mg/25ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #9300
This multinational pharmaceutical corporation specializes in developing, manufacturing, and distributing prescription injectable medications globally. Their focus lies in therapeutic areas such as oncology, urology, central nervous system disorders, and infectious diseases. They are committed to research and development (R&D) to deliver advanced medicines. While specific regions and production lines aren't mentioned, their international reach suggests a presence across multiple continents. Key dosage forms likely include vials and ampoules for injectable delivery. The company emphasizes quality and reliability with potential GMP certifications.

Manufacturer usually replies in 3 days

irinotecan

Injection, lyophilized 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #31064

Established in 1970, this Chinese manufacturer specializes in the research, development, production, and sales of a wide range of pharmaceutical products. As a CTD dossier owner and manufacturer, it ensures compliance with international quality standards. The company operates advanced production lines across four industrial parks, covering approximately 1,333,400 square meters, and employs nearly 5,000 individuals, including over 2,000 professional and technical personnel. Its diverse product portfolio includes anesthetic agents, psychotropic medicines, nonsteroidal anti-inflammatory drugs, cardiovascular system medicines, antibiotics, and antiviral medicines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide. The manufacturer holds GMP certifications from international regulatory authorities, including the U.S. FDA and the Philippines FDA, ensuring adherence to stringent global quality standards

Manufacturer usually replies in 5 days

irinotecan

Solution for injection 0.1g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #16892
This company is a global product and service provider specializing in the chemical and pharmaceutical industries. They import and export a wide range of products, including pharmaceutical raw materials, intermediates, dyes, pesticides, basic chemicals, fine chemicals, food additives, and medical preparations. They also offer technical services such as research and customization for the chemical and pharmaceutical sectors, along with testing services that encompass safety, quality control, and composition analysis. While their primary focus is on supplying these products to various regions across the globe, including North America, Europe, and Asia, they are actively expanding into new markets.

Manufacturer usually replies in 6 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

What is the Irinotecan drug?

Irinotecan is an antineoplastic enzyme inhibitor; it reduces the spread of the cancer cells in the body. It is a medication used to treat colon cancer and small cell lung cancer. Irinotecan is usually administered during chemotherapy as a single agent or in combination with other drugs.
The FDA, in the US, approved the medical use of Irinotecan medication in 1996. Irinotecan is on the WHO's List of Essential Medicines, the safest and most effective medicines needed in a health system. The natural compound camptothecin found in the Chineses ornamental tree Camptotheca acuminata is used to make the Irinotecan medication.

Irinotecan manufacturers and wholesalers:

The US brand name for Irinotecan is Camptosar. Irinotecan is a globally found drug. Among all the manufacturers, we can list some, such as Pfizer Inc, Accord Healthcare Inc, Actavis Totowa Llc, Teva Parenteral Medicines Inc, and Watson Laboratories Inc.
Irinotecan suppliers market it in the forms of 20 mg solutions or solutions for injection. Under the generic names, for injection of Irinotecan, the drug can be found at different dosages: 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml; 500 mg/25 ml. For Camptosar, the solution for injection can be marketed in the strength of 40 mg/2 ml; 100 mg/5 ml; 300 mg/15 ml.

Irinotecan for sales:

On the US market, the price of Irinotecan can vary if it is sold under the generic name or the brand name. For 20mg/ml of an intravenous solution of Irinotecan, it can cost from $17 to $202 for 2ml, about $19.60 for 5ml, and about $131.30 for 25ml. The prices for Irinotecan under the brand name Camptosar are slightly different. For Camptosar 20 mg/ml intravenous solution, 2 ml costs about $35.60, 5 ml about $48.48, and for 15ml, it costs about $126.43
As Irinotecan is a globally found drug, you may encounter fraudulent online websites that will want to sell Irinotecan with some risks for you and your clients. By using Pipelinepharma B2B marketplace, you avoid time-consuming sourcing, and you directly find qualified sellers of Irinotecan. Those manufacturers and distributors have been through quality control procedures to ensure they were qualified partners. On the online platform, Irinotecan is mostly available from the EU, India, Argentina, Turkey, China, and Ukraine. Thanks to the intuitive online marketplace, you will find Irinotecan and many other drugs quickly and efficiently. Placing an order has never been easier than with Pipelinepharma. Let us connect you with Irinotecan. Manufacturers and distributors.

How to use Irinotecan drugs?

Using Irinotecan medication as a single agent for the treatment of colorectal cancer, an adult should be administered 125 mg/m2 IV over 90 minutes on Days 1, 8, 15, and 22 then 2-week rest or 350 mg/m2 IV over 90 minutes on Day 1 every three weeks.
Taking Irinotecan can cause some side effects, the most common ones are severe diarrhea, black, tarry stools, blood in the urine or stools, blurred vision, changes in skin color, and chest pain or discomfort.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible